معرفی
Dr. Robert W. Yeh is a Professor of Medicine at Harvard Medical School, Section Chief of Interventional Cardiology at Beth Israel Deaconess Medical Center, and Director of the Smith Center for Outcomes Research. His work bridges clinical trials, observational studies, and healthcare informatics to evaluate cardiovascular technologies.
- Specializes in real-world data integration (CMS, ACC registries)
- Developed the DAPT Score, a guideline-endorsed clinical decision tool
- Principal Investigator for NIH-funded EXTEND Study on pragmatic trial design
Recent publications focus on antiplatelet therapy optimization, drug-coated balloons, and cardiometabolic risk prediction. His research spans cardiovascular devices, bleeding risk assessment, and data-driven clinical guidelines.
Scientific contributions include:
- DAPT Study leadership (international RCT on antiplatelet duration)
- EXTEND Study (NIH-funded real-world data validation)
- Collaboration with American Heart Association for epidemiological reports
Dr. Yeh’s educational background combines clinical and business expertise: MD from Harvard, MBA from Oxford, and Health Policy Masters from University of London. He actively mentors researchers in cardiovascular outcomes and interventional cardiology.
